Company: REVB
Filing Date: 2025-05-23
Form Type: S-1/A
Source: 0001213900-25-047104
Chunk: 92

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-23
Form: S-1/A
Chunk 92
---
.0 million from the February 2023 Public Offering (defined below). Contractual Obligations and Other Commitments The following table summarizes our contractual obligations as of December 31, 2024 and the effects of such obligations are expected to have on our liquidity and cash flow in future periods:

|                               |     | Less than 
 1 year    |        |     | 1 to 3 
 years  |   |     | 3 to 5 
 years  |   |     | More than 
 5 years   |   |     | Total |        |
|:------------------------------|:----|:----------|-------:|:----|:-------|:--|:----|:-------|:--|:----|:----------|:--|:----|:------|-------:|
| Operating lease obligations   |     | $         | 10,700 |     | $      | — |     | $      | — |     | $         | — |     | $     | 10,700 |
| Total contractual obligations |     | $         | 10,700 |     | $      | — |     | $      | — |     | $         | — |     | $     | 10,700 |

We have entered into an operating lease for laboratory space in San Diego, California. The table above includes future minimum lease payments under the non-cancelable lease arrangement. We enter into contracts in the normal course of business with third party service providers and vendors. These contracts generally provide for termination on notice and, therefore, are cancellable contracts and not considered contractual obligations and commitments. We believe that our non-cancelable obligations under these agreements are not material. Off-Balance Sheet Arrangements As of March 31, 2025, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K. Quantitative and Qualitative Disclosure about Market Risk We are exposed to market risks in the ordinary course of our business. Interest Rate Risk Our cash and cash equivalents consist primarily of highly liquid investments in money market funds and cash on hand and have an original maturity date of 90 days or less. The fair value of our cash and cash equivalents would not be significantly affected by either an increase or decrease in interest rates due mainly to the short-term nature of these instruments. Foreign Currency Risk Our expenses are generally denominated in the currencies in which our operations are located, which is primarily in the United States